Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chi-Long Chen

Showing results (101-110 of 135) with videos related to

Pageof 14
Sort By:
Critical Care Medicine|April 2, 2008
Establishment of a young mouse model and identification of an allelic variation of zmpB in complicated pneumonia caused by Streptococcus pneumoniaeYu-Chia Hsieh, Po-Nien Tsao, Chi-Long Chen, et al.
Cell Death Discovery|March 6, 2022
FAS receptor regulates NOTCH activity through ERK-JAG1 axis activation and controls oral cancer stemness ability and pulmonary metastasisLi-Jie Li, Peter Mu-Hsin Chang, Chien-Hsiu Li, et al.
Cell Death & Disease|September 4, 2024
B4GALT1-dependent galectin-8 binding with TGF-β receptor suppresses colorectal cancer progression and metastasisTzu-Hui Hsu, Yu-Chan Chang, Yi-Yuan Lee, et al.
Journal of Hematology & Oncology|January 8, 2017
Glucose transporter 4 promotes head and neck squamous cell carcinoma metastasis through the TRIM24-DDX58 axisYu-Chan Chang, Li-Hsing Chi, Wei-Ming Chang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 10, 2009
Chromosome 3p12.3-p14.2 and 3q26.2-q26.32 are genomic markers for prognosis of advanced nasopharyngeal carcinomaJim Jinn-Chyuan Sheu, Chia-Huei Lee, Jenq-Yuh Ko, et al.
Molecular Cancer Therapeutics|August 19, 2010
From NPC therapeutic target identification to potential treatment strategyMing-Ying Lan, Chi-Long Chen, Kuan-Ting Lin, et al.
Scientific Reports|January 26, 2017
Parathyroid Hormone-Like Hormone is a Poor Prognosis Marker of Head and Neck Cancer and Promotes Cell Growth via RUNX2 RegulationWei-Min Chang, Yuan-Feng Lin, Chia-Yi Su, et al.
Biochimica Et Biophysica Acta|June 11, 2014
MicroRNA-296-5p (miR-296-5p) functions as a tumor suppressor in prostate cancer by directly targeting Pin1Kuen-Haur Lee, Forn-Chia Lin, Tai-I Hsu, et al.
International Journal of Biological Sciences|September 23, 2024
ESM1 facilitates the EGFR/HER3-triggered epithelial-to-mesenchymal transition and progression of gastric cancer via modulating interplay between Akt and angiopoietin-2 signalingYi-Chieh Yang, Ko-Hao Ho, Ke-Fan Pan, et al.
Cell Death Discovery|October 7, 2025
Targeting ESR1 restores SQSTM1-dependent autophagy and sensitizes ER-positive breast cancer to oxidative and radiation stressYi-Fang Yang, Zhao-Jing He, Han-Hsi Kuo, et al.
Pageof 14

Showing results (101-110 of 135) with videos related to

Sort By:
Pageof 14
Critical Care Medicine|April 2, 2008
Establishment of a young mouse model and identification of an allelic variation of zmpB in complicated pneumonia caused by Streptococcus pneumoniaeYu-Chia Hsieh, Po-Nien Tsao, Chi-Long Chen, et al.
Cell Death Discovery|March 6, 2022
FAS receptor regulates NOTCH activity through ERK-JAG1 axis activation and controls oral cancer stemness ability and pulmonary metastasisLi-Jie Li, Peter Mu-Hsin Chang, Chien-Hsiu Li, et al.
Cell Death & Disease|September 4, 2024
B4GALT1-dependent galectin-8 binding with TGF-β receptor suppresses colorectal cancer progression and metastasisTzu-Hui Hsu, Yu-Chan Chang, Yi-Yuan Lee, et al.
Journal of Hematology & Oncology|January 8, 2017
Glucose transporter 4 promotes head and neck squamous cell carcinoma metastasis through the TRIM24-DDX58 axisYu-Chan Chang, Li-Hsing Chi, Wei-Ming Chang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 10, 2009
Chromosome 3p12.3-p14.2 and 3q26.2-q26.32 are genomic markers for prognosis of advanced nasopharyngeal carcinomaJim Jinn-Chyuan Sheu, Chia-Huei Lee, Jenq-Yuh Ko, et al.
Molecular Cancer Therapeutics|August 19, 2010
From NPC therapeutic target identification to potential treatment strategyMing-Ying Lan, Chi-Long Chen, Kuan-Ting Lin, et al.
Scientific Reports|January 26, 2017
Parathyroid Hormone-Like Hormone is a Poor Prognosis Marker of Head and Neck Cancer and Promotes Cell Growth via RUNX2 RegulationWei-Min Chang, Yuan-Feng Lin, Chia-Yi Su, et al.
Biochimica Et Biophysica Acta|June 11, 2014
MicroRNA-296-5p (miR-296-5p) functions as a tumor suppressor in prostate cancer by directly targeting Pin1Kuen-Haur Lee, Forn-Chia Lin, Tai-I Hsu, et al.
International Journal of Biological Sciences|September 23, 2024
ESM1 facilitates the EGFR/HER3-triggered epithelial-to-mesenchymal transition and progression of gastric cancer via modulating interplay between Akt and angiopoietin-2 signalingYi-Chieh Yang, Ko-Hao Ho, Ke-Fan Pan, et al.
Cell Death Discovery|October 7, 2025
Targeting ESR1 restores SQSTM1-dependent autophagy and sensitizes ER-positive breast cancer to oxidative and radiation stressYi-Fang Yang, Zhao-Jing He, Han-Hsi Kuo, et al.
Pageof 14